Also, while it is established that RhoC is relevant to breast cancer survival (via cell death inhibition) and progression (via the promotion of proliferation, invasion, and metastasis), data accumulated so far only reveals the relevance of RhoA to breast cancer cell progression. Here, RHOC is linked to breast carcinoma.